Total saponins of Aralia taibaiensis protects myocardial cells against oxidative stress through the

来源 :2013中国药学大会暨第十三届中国药师周 | 被引量 : 0次 | 上传用户:linxiaotu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: Patients with type 2 diabetes have increased cardiovascular disease risk compared with those without diabetes.Hyperglycemia can induce reactive oxygen species (ROS) generation,which contributes to development of diabetic cardiomyopathy.Our previous study has demonstrated that total saponins of Aralia taibaiensis (sAT),a frequently-used antidiabetic in traditional Chinese medicine (TCM),can scavenge free radicals in vivo and have good antioxidant ability on lipid peroxidation of rat liver microsomes.To investigate whether sAT could protect the heart,while it was in the treatment of diabetes,we designed this study to elucidate cardioprotective effects of sAT.Methods and results: Oxidative stress was induced in H9c2 cells by high glucose (33 mM) and glucose oxidase (15mU) and the protective effects of sAT were evaluated.Treatment of H9c2 cells with G/GO resulted in an increase in cell death,intracellular ROS level and cell oxidative injury,which were markedly reduced by sAT treatment.Further study revealed that sAT induced the nuclear translocation of Nrf2,enhanced the expression of Nrf2-related antioxidant proteins heme oxygenase (HO-1) and NAD (P) H quinone oxidoreductase-1 (NQO-1).Inhibition of Nrf2 by siRNA reduced sAT-induced upregulation of these antioxidant genes.Western blotting and luciferase assay revealed sAT activated Nrf2 via the PI3K/Akt pathway.Moreover,Nrf2 siRNA markedly reduced the cytoprotective effects of sAT.Conclusions: sAT exerts cytoprotective effects against oxidative stress induced by hyperglycemia.This cardioprotection is mediated,at least in part,through PI3K/Akt/Nrf2 pathways,which further activates Nrf2-regulated antioxidant enzymes.sAT might be a promising candidate for the treatment of diabetic cardiomyopathy.
其他文献
目的:探讨MR对直肠癌新辅助治疗后再分期的准确性。方法:收集本院2009年1月至2012年3月病理证实为直肠癌患者29例,新辅助治疗后(术前放射治疗或放化疗同步)MRI图像显示肿瘤的侵犯范围、淋巴结转移情况及影像学T、N分期与术后病理学结果进行对照分析。结果:29例直肠癌患者,24例男性,5例女性,平均年龄49岁(24-68岁),均为腺癌,其中两例为黏液细胞癌;根据MR图像资料评估新辅助治疗后直肠
目的:建立一种用于A群、C群、W135群和Y群四价流脑结合疫苗制品中各血清群多糖蛋白结合物的定量检测方法.方法:制备了抗载体蛋白白喉毒素无毒变异体(CRM197)和流脑4个血清群多糖的特异性单克隆抗体,并建立了用CRM197特异性单抗为包被抗体,辣根过氧化物酶(HRP)标记的流脑各血清群多糖的单抗为捕获抗体,可定量检测流脑各血清群结合物含量的双抗体夹心ELISA法.结果:定量检测A 群流脑结合物(
Background: The aim of this study is to compare the efficacy and safety of ertapenem with ceftriaxone based therapy,which has been demonstrated to be highly effective for the complicated infections.Me
目的:通过查阅国内外抗真菌药肝毒性相关文献,运用文献计量学的方法统计和分析国内外抗真菌药的肝毒性相关的研究现状,确保临床用药安全性,为研究高效、低毒抗真菌药提供参考和借鉴.方法:在Cnki、Cbmdisc、PubMed、Web of Science、Embase数据库中检索所有有关抗真菌药的肝毒性方面的文献,按照文献的发表年份、作者、研究机构、文章类型、发表期刊被引频次、抗真菌药物分类等进行统计分
目的:从文献计量学角度对国内外社区获得性耐甲氧西林金黄色葡萄球菌的相关文献进行分析,旨在为CA-MRSA深入研究提供参考和借鉴.方法:英文文献检索Pubmed、Embase、SCI数据库中CA-MRSA相关文献;中文检索CNKI期刊全文数据库、维普和SinoMed数据库中CA-MRSA相关文献,截止日期均为2013年4月;利用ENDNOTE2.0软件进行分类整理,对纳入研究文献的发表年份、作者、发
目的:分析Pubmed、Embase、SCI、SinoMed四个数据库,了解抗真菌药治疗药物监测研究进展,为临床合理应用抗真菌药提供参考,保障患者用药安全性.方法:在Pubmed、Embase、SCI、SinoMed数据库中检索全部相关文献,对纳入研究的文献的发表年份、作者及研究机构、文章类型、引频、期刊等进行统计分析。结果:共检索出388篇相关文献,文献量近十年增加较快,近年来随着抗真菌药的广泛
探索姜黄素(curcumin,cur)对血管紧张素Ⅱ(Angiotensin Ⅱ,AngⅡ)所致内皮细胞损伤模型的保护作用.用10-6mol·L-1 AngⅡ构建内皮细胞损伤模型.Real time-PCR检测各组内皮细胞CD40、eNOS、DDAH1、DDAH2 mRNA表达变化,并用Western Blot方法检测各组内皮细胞CD40表达变化情况,试剂盒测定细胞中超氧化物歧化酶(SOD)、过氧
目的:探讨阿魏酸对红藻氨酸诱导PC12细胞凋亡的保护作用机制.方法:采用50.0μmol.L-1KA诱导PC12细胞凋亡建立AD神经细胞模型,然后将处理后的PC12细胞分为KA模型组和KA+阿魏酸(25.0,50.0,100.0μmol.L-1)处理的低、中、高剂量组,同时设立正常对照组.采用MTT比色法检测PC12细胞的存活率;采用免疫细胞化学法观察PC12细胞中凋亡蛋白Bcl-2、Bax和Cy
目的:从文献计量学的角度对国内外磷霉素的相关文献进行分析,了解磷霉素对耐药菌感染的临床研究进展和现状,为磷霉素的深入研究提供参考和借鉴.方法:以“fosfomycin、phosphonomycin、phosphormycin”为英文检索Embase、Pubmed、Web of Science 数据库中磷霉素相关文献;中文检索CNKI期刊全文数据库中磷霉素的相关文献,截止日期2013年7月.利用En